The message in the air: Hydrogen sulfide metabolism in chronic respiratory diseases

Respiratory Physiology & Neurobiology - Tập 184 - Trang 130-138 - 2012
Yahong Chen1, Rui Wang2
1Respiratory Department, Peking University Third Hospital, Beijing, China
2Department of Biology, Lakehead University, Thunder Bay, Ontario, Canada

Tài liệu tham khảo

Ang, 2010, Hydrogen sulfide promotes transient receptor potential vanilloid 1-mediated neurogenic inflammation in polymicrobial sepsis, Crit. Care Med., 38, 619, 10.1097/CCM.0b013e3181c0df00 Anthonisen, 1987, Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease, Ann. Intern. Med., 106, 196, 10.7326/0003-4819-106-2-196 Badesch, 2007, Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines, Chest, 131, 1917, 10.1378/chest.06-2674 Barker, 2006, Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis, Eur. Respir. J., 27, 929, 10.1183/09031936.06.00085105 Barnes, 2005, Theophylline in chronic obstructive pulmonary disease: new horizons, Proc. Am. Thorac. Soc., 2, 334, 10.1513/pats.200504-024SR Barnes, 2010, Exhaled nitric oxide in pulmonary diseases: a comprehensive review, Chest, 138, 682, 10.1378/chest.09-2090 Baskar, 2007, Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells, FASEB J., 21, 247, 10.1096/fj.06-6255com Bateman, 2008, Global strategy for asthma management and prevention: GINA executive summary, Eur. Respir. J., 31, 143, 10.1183/09031936.00138707 Beauchamp, 1984, A critical review of the literature on hydrogen sulfide toxicity, Crit. Rev. Toxicol., 13, 25, 10.3109/10408448409029321 Belley, 2005, Hyperbaric oxygen therapy in the management of two cases of hydrogen sulfide toxicity from liquid manure, CJEM, 7, 257, 10.1017/S1481803500014408 Benavides, 2007, Hydrogen sulfide mediates the vasoactivity of garlic, Proc. Natl. Acad. Sci. U.S.A., 104, 17977, 10.1073/pnas.0705710104 Bergeron, 2010, Airway remodelling in asthma: from benchside to clinical practice, Can. Respir. J., 17, e85, 10.1155/2010/318029 Bhatia, 2006, Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice, Am. J. Physiol. Lung Cell Mol. Physiol., 291, L896, 10.1152/ajplung.00053.2006 Bitterman, 1986, The effect of hyperbaric oxygen on acute experimental sulfide poisoning in the rat, Toxic Appl. Pharmacol., 84, 325, 10.1016/0041-008X(86)90140-7 Braga, 2010, Effects of sulphurous water on human neutrophil elastase release, Ther. Adv. Respir. Dis., 4, 333, 10.1177/1753465810376783 Burnett, 1977, Hydrogen sulfide poisoning: review of 5 years’ experience, Can. Med. Assoc. J., 117, 1277 Chapman, 2011, Epithelial–mesenchymal interactions in pulmonary fibrosis, Annu. Rev. Physiol., 73, 413, 10.1146/annurev-physiol-012110-142225 Chen, 2004, Production of the neuromodulator H2S by cystathionine beta-synthase via the condensation of cysteine and homocysteine, J. Biol. Chem., 279, 52082, 10.1074/jbc.C400481200 Chen, 2008, Effect of theophylline on endogenous hydrogen sulfide production in patients with COPD, Pulm. Pharmacol. Ther., 21, 40, 10.1016/j.pupt.2006.11.002 Chen, 2011, Involvement of endogenous hydrogen sulfide in cigarette smoke-induced changes in airway responsiveness and inflammation of rat lung, Cytokine, 53, 334, 10.1016/j.cyto.2010.12.006 Chen, 2009, Endogenous hydrogen sulfide reduces airway inflammation and remodeling in a rat model of asthma, Cytokine, 45, 117, 10.1016/j.cyto.2008.11.009 Chen, 2009, Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections, Respirology, 14, 746, 10.1111/j.1440-1843.2009.01550.x Chen, 2005, Endogenous hydrogen sulfide in patients with COPD, Chest, 128, 3205, 10.1378/chest.128.5.3205 Christ-Crain, 2004, Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial, Lancet, 363, 600, 10.1016/S0140-6736(04)15591-8 Chunyu, 2003, The regulatory effect of hydrogen sulfide on hypoxic pulmonary hypertension in rats, Biochem. Biophys. Res. Commun., 302, 810, 10.1016/S0006-291X(03)00256-0 Coward, 2010, The pathogenesis of idiopathic pulmonary fibrosis, Ther. Adv. Respir. Dis., 4, 367, 10.1177/1753465810379801 Drakopanagiotakis, 2008, Apoptosis in lung injury and fibrosis, Eur. Respir. J., 32, 1631, 10.1183/09031936.00176807 Duong, 2001, Interstitial fibrosis following hydrogen sulfide exposure, Am. J. Ind. Med., 40, 221, 10.1002/ajim.1091 Dweik, 2011, An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications, Am. J. Respir. Crit. Care Med., 184, 602, 10.1164/rccm.9120-11ST Evans, 2011, Hypoxic pulmonary vasoconstriction: mechanisms of oxygen-sensing, Curr. Opin. Anaesthesiol., 24, 13, 10.1097/ACO.0b013e3283421201 Fang, 2009, Hydrogen sulfide suppresses migration, proliferation and myofibroblast transdifferentiation of human lung fibroblasts, Pulm. Pharmacol. Ther., 22, 554, 10.1016/j.pupt.2009.07.003 Fang, 2010, Hydrogen sulfide attenuates epithelial–mesenchymal transition of human alveolar epithelial cells, Pharmacol. Res., 61, 298, 10.1016/j.phrs.2009.10.008 Gajdocsy, 2010, Exhaled carbon monoxide in airway diseases: from research findings to clinical relevance, J. Breath Res., 4, 47102, 10.1088/1752-7155/4/4/047102 Geppetti, 2006, The transient receptor potential vanilloid 1: role in airway inflammation and disease, Eur. J. Pharmacol., 533, 207, 10.1016/j.ejphar.2005.12.063 Gharaee-Kermani, 2009, Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast, Curr. Med. Chem., 16, 1400, 10.2174/092986709787846497 Guidotti, 1994, Occupational exposure to hydrogen sulfide in the sour gas industry: some unresolved issues, Int. Arch. Occup. Environ. Health, 66, 153, 10.1007/BF00380773 Guidotti, 1996, Hydrogen sulphide, Occup. Med. (Lond.), 46, 367, 10.1093/occmed/46.5.367 Gunn, 2001, Noxious gas exposure in the outback: two cases of hydrogen sulfide toxicity, Emerg. Med. (Fremantle), 13, 240, 10.1046/j.1442-2026.2001.00220.x Han, 2011, Hydrogen sulfide ameliorates tobacco smoke-induced oxidative stress and emphysema in mice, Antioxid. Redox Signal., 15, 2121, 10.1089/ars.2010.3821 Hillas, 2009, Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?, Curr. Med. Chem., 16, 2824, 10.2174/092986709788803178 Jeffery, 2004, Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease, Proc. Am. Thorac. Soc., 1, 176, 10.1513/pats.200402-009MS Jin, 2006, Effects of hydrogen sulfide on hypoxic pulmonary vascular structural remodeling, Life Sci., 78, 1299, 10.1016/j.lfs.2005.07.009 Kamboures, 2005, Breath sulfides and pulmonary function in cystic fibrosis, Proc. Natl. Acad. Sci. U.S.A., 102, 15762, 10.1073/pnas.0507263102 Kubo, 2007, Hydrogen sulfide causes relaxation in mouse bronchial smooth muscle, J. Pharmacol. Sci., 104, 392, 10.1254/jphs.SC0070199 Li, 2009, Actions and interactions of nitric oxide, carbon monoxide and hydrogen sulphide in the cardiovascular system and in inflammation—a tale of three gases!, Pharmacol. Ther., 123, 386, 10.1016/j.pharmthera.2009.05.005 Li, 2010, Regulative mechanism of budesonide on endogenous hydrogen sulfide, cystathionine-gamma-lyase and cystathionine-beta-synthase system in asthmatic rats, Zhongguo Dang Dai Er Ke Za Zhi, 12, 654 Lim, 2008, Vasoconstrictive effect of hydrogen sulfide involves downregulation of cAMP in vascular smooth muscle cells, Am. J. Physiol. Cell Physiol., 295, C1261, 10.1152/ajpcell.00195.2008 Lindenmann, 2010, Hyperbaric oxygen in the treatment of hydrogen sulphide intoxication, Acta Anaesthesiol. Scand., 54, 784, 10.1111/j.1399-6576.2009.02187.x Macnee, 2010, Right heart function in COPD, Semin. Respir. Crit. Care Med., 31, 295, 10.1055/s-0030-1254070 Mancuso, 2010, Roles of nitric oxide, carbon monoxide, and hydrogen sulfide in the regulation of the hypothalamic–pituitary–adrenal axis, J. Neurochem., 113, 563, 10.1111/j.1471-4159.2010.06606.x Milby, 1962, Hydrogen sulfide intoxication. Review of the literature and report of unusual accident resulting in two cases of nonfatal poisoning, J. Occup. Med., 4, 431 Milby, 1999, Hydrogen sulfide poisoning: clarification of some controversial issues, Am. J. Ind. Med., 35, 192, 10.1002/(SICI)1097-0274(199902)35:2<192::AID-AJIM11>3.0.CO;2-C Morselli-Labate, 2007, Hydrogen sulfide, nitric oxide and a molecular mass 66 u substance in the exhaled breath of chronic pancreatitis patients, Pancreatology, 7, 497, 10.1159/000108967 Mustafa, 2011, Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels, Circ. Res., 109, 1259, 10.1161/CIRCRESAHA.111.240242 Olson, 2010, Hypoxic pulmonary vasodilation: a paradigm shift with a hydrogen sulfide mechanism, Am. J. Physiol. Regul. Integr. Comp. Physiol., 298, R51, 10.1152/ajpregu.00576.2009 Peng, 2010, H2S mediates O2 sensing in the carotid body, Proc. Natl. Acad. Sci. U.S.A., 107, 10719, 10.1073/pnas.1005866107 Perry, 2011, Hydrogen sulfide inhibits proliferation and release of IL-8 from human airway smooth muscle cells, Am. J. Respir. Cell Mol. Biol., 45, 746, 10.1165/rcmb.2010-0304OC Qingyou, 2004, Impact of hydrogen sulfide on carbon monoxide/heme oxygenase pathway in the pathogenesis of hypoxic pulmonary hypertension, Biochem. Biophys. Res. Commun., 317, 30, 10.1016/j.bbrc.2004.02.176 Rabe, 2007, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary, Am. J. Respir. Crit. Care Med., 176, 532, 10.1164/rccm.200703-456SO Raghu, 2011, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am. J. Respir. Crit. Care Med., 183, 788, 10.1164/rccm.2009-040GL Raval, 2010, Heme oxygenase-1 in lung disease, Curr. Drug Targets, 11, 1532, 10.2174/1389450111009011532 Sethi, 2004, Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?, Proc. Am. Thorac. Soc., 1, 109, 10.1513/pats.2306029 Shaji, 2010, Breath biomarker for clinical diagnosis and different analysis technique, Res. J. Pharm. Biol. Chem. Sci., 1, 639 Shibuya, 2009, Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide, J. Biochem., 146, 623, 10.1093/jb/mvp111 Studer, 2001, Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection, J. Heart Lung Transplant, 20, 1158, 10.1016/S1053-2498(01)00343-6 Tanaka, 1999, Bronchial injury and pulmonary edema caused by hydrogen sulfide poisoning, Am. J. Emerg. Med., 17, 427, 10.1016/S0735-6757(99)90102-X Tashkin, 1992, The lung health study: airway responsiveness to inhaled methacholine in smokers with mild to moderate airflow limitation. The Lung Health Study Research Group, Am. Rev. Respir. Dis., 145, 301, 10.1164/ajrccm/145.2_Pt_1.301 Trevisani, 2005, Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways, Br. J. Pharmacol., 145, 1123, 10.1038/sj.bjp.0706277 Wang, 2011, Hydrogen sulfide and asthma, Exp. Physiol., 96, 847, 10.1113/expphysiol.2011.057448 Wang, 2002, Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?, FASEB J., 16, 1792, 10.1096/fj.02-0211hyp Wang, 2009, Hydrogen sulfide: a new EDRF, Kidney Int., 76, 700, 10.1038/ki.2009.221 Wang, 2010, Hydrogen sulfide: the third gasotransmitter in biology and medicine, Antioxid. Redox Signal., 12, 1061, 10.1089/ars.2009.2938 Wang, 2010, Toxic gas, lifesaver, Sci. Am., 302, 66, 10.1038/scientificamerican0310-66 Wei, 2008, Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats, Acta Pharmacol. Sin., 29, 670, 10.1111/j.1745-7254.2008.00796.x Wu, 2008, Plasma level of endogenous hydrogen sulfide in patients with acute asthma, Beijing Da Xue Xue Bao, 40, 505 Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J. Exp. Med., 208, 1339, 10.1084/jem.20110551